Volicure 0.3mg Tablet
Marketer
HBC Lifesciences Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Volicure 0.3mg Tablet
Diabetic patients with uncontrolled type 2 diabetes, despite dietary management and other medications, may benefit from Glicemia 0.3mg tablets. This medication aids postprandial blood glucose regulation. Dosage and frequency are determined individually by your physician to optimize blood sugar control. Abrupt cessation is strongly discouraged; consult your doctor first, as this can cause dangerously high blood sugar levels, potentially leading to serious complications such as renal impairment and vision loss. Glicemia 0.3mg tablets form part of a comprehensive treatment strategy encompassing a balanced diet, regular physical activity, and weight management as directed by your physician. Regular blood glucose monitoring is essential. Common side effects include gastrointestinal discomfort (e.g., bloating, abdominal pain, appetite changes, constipation, diarrhea). Report persistent or troublesome side effects to your doctor. While Glicemia 0.3mg tablets alone don't cause hypoglycemia, combining them with other antidiabetic agents (particularly insulin or sulfonylureas) elevates this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your doctor of any pre-existing liver or kidney conditions, or bowel inflammation (e.g., Crohn's disease or ulcerative colitis) before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Always disclose all current medications to ensure medication safety. Excessive alcohol consumption should be avoided due to the increased hypoglycemia risk.
Primary Ingredients of Volicure 0.3mg Tablet
The provided text is "undefined," so no rephrasing is possible.
Uses of Volicure 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Volicure 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Volicure 0.3mg Tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.
Common Side effects of Volicure 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Volicure 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Volicure 0.3mg Tablet on an empty stomach.
How Volicure 0.3mg Tablet works:
Glucodown 0.3mg tablets offer anti-diabetic action by suppressing the activity of intestinal enzymes that digest complex carbohydrates. This mechanism reduces postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Volicure 0.3mg tablets with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Volicure 0.3mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; despite this, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Based on limited available data from humans, the use of 0.3mg Volicure tablets while breastfeeding is considered likely safe, posing minimal apparent risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Volicure 0.3mg tablets.
KidneyCAUTION
Patients with severe renal impairment should use Volicure 0.3mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Volicure 0.3mg tablets. Dosage modification of Volicure 0.3mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Volicure 0.3mg Tablet :
Omit any missed Volicure 0.3mg Tablet dose and resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Volicure 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently